- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 275/02 - Heterocyclic compounds containing 1, 2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
Patent holdings for IPC class C07D 275/02
Total number of patents in this class: 222
10-year publication summary
|
11
|
17
|
2
|
15
|
13
|
8
|
15
|
15
|
7
|
5
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Janssen Pharmaceutica N.V. | 3392 |
9 |
| Syngenta Participations AG | 1903 |
7 |
| Ihara Chemical Industry Co., Ltd. | 71 |
6 |
| Bristol-myers Squibb Company | 4898 |
5 |
| BASF SE | 20933 |
5 |
| Centaurus Biopharma Co., Ltd. | 82 |
5 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 702 |
5 |
| Lianyungang Runzhong Pharmaceutical Co., Ltd. | 84 |
5 |
| Grey Wolf Therapeutics Limited | 16 |
5 |
| F. Hoffmann-La Roche AG | 7925 |
4 |
| Abbott Laboratories | 2399 |
4 |
| Allergan, Inc. | 2349 |
4 |
| Bayer Pharma AG | 1052 |
4 |
| Mochida Pharmaceutical Co., Ltd. | 337 |
4 |
| Texas Heart Institute | 104 |
4 |
| Tango Therapeutics, Inc. | 45 |
4 |
| Orsobio, Inc. | 13 |
4 |
| AstraZeneca AB | 2909 |
3 |
| Kumiai Chemical Industry Co., Ltd. | 311 |
3 |
| Mitsubishi Tanabe Pharma Corporation | 579 |
3 |
| Other owners | 129 |